Skye Bioscience Inc

Embark on a global cannabis expedition: Ontario doubles its store count, Australia sees a rise in exports, and a novel partnership that targets medical cannabis development in Africa. Ontario's Store Increase Ontario, Canada plans to double its cannabis store cap to 150. This expansion aims to...

Biomed company Skye Bioscience (OTCQB: SKYE) has seen positive results in its clinical research so far and is preparing for the next stage in the development of its therapy for eye disease.  Glaucoma is a widespread eye disease and is the second leading cause of blindness globally. When the...

Cannabinoid receptors distributed within the body are part of the endocannabinoid system that largely affects processes such as mood, memory, pain-sensation, and appetite, to name a few. Two types of receptors — CB1 and CB2 — “play a vital role in managing different body...